CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jul 29, 11:26

Vir Biotechnology (VIR) Expected to Post Earnings on Wednesday

Vir Biotechnology Inc
Webhose 2026 Jul 29, 07:12

ADAR1 Capital Management LLC Invests $24.59 Million in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Jul 29, 04:27

Vir Biotechnology (VIR) Expected to Announce Earnings on Wednesday - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jul 28, 10:34

Eversept Partners LP Takes $2.24 Million Position in Vir Biotechnology, Inc. $VIR - Zolmax

Vir Biotechnology Inc
Webhose 2026 Jul 28, 07:53

Empyrean Capital Partners LP Invests $4.73 Million in Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Jul 24, 13:01

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next? - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 23, 10:30

Monashee Investment Management LLC Makes New Investment in Vir Biotechnology, Inc. $VIR - Markets Daily

Vir Biotechnology Inc
Webhose 2026 Jul 23, 06:30

Monashee Investment Management LLC Takes Position in Vir Biotechnology, Inc. $VIR - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 17, 04:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jul 13, 08:28

Vir Biotechnology, Inc. $VIR Shares Acquired by Candriam S.C.A. - Zolmax

Vir Biotechnology Inc
Webhose 2026 Jul 13, 07:52

Vir Biotechnology, Inc. $VIR Shares Bought by Candriam S.C.A.

Vir Biotechnology Inc
Webhose 2026 Jul 03, 02:56

Vir Biotechnology, Inc. $VIR Stock Holdings Increased by Pictet Asset Management Holding SA - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 30, 06:02

113,028 Shares in Vir Biotechnology, Inc. $VIR Purchased by OP Asset Management Ltd - Stock Observer

Vir Biotechnology Inc

VirBiotechnology news

Latest news

Info

Spread

0.08

Spread (%)

0.9259 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1492569984

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.15

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now

Latest Education Articles

Trustpilot